HomePSTV • NASDAQ
add
Plus Therapeutics Inc
Previous close
$1.28
Day range
$1.23 - $1.28
Year range
$1.12 - $2.67
Market cap
6.85M USD
Avg Volume
98.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.46M | 17.42% |
Operating expense | 2.40M | 19.97% |
Net income | -2.87M | 10.72% |
Net profit margin | -197.39 | 23.96% |
Earnings per share | -0.37 | 63.00% |
EBITDA | -3.60M | -16.43% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.79M | -56.50% |
Total assets | 6.98M | -47.45% |
Total liabilities | 12.15M | 14.04% |
Total equity | -5.17M | — |
Shares outstanding | 5.90M | — |
Price to book | -1.45 | — |
Return on assets | -104.43% | — |
Return on capital | 318.44% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.87M | 10.72% |
Cash from operations | -3.68M | -53.40% |
Cash from investing | -9.00K | 10.00% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -3.69M | -3,423.42% |
Free cash flow | -8.35M | -525.46% |
About
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. The company is headquartered in Austin, Texas, United States. Wikipedia
Founded
1996
Headquarters
Website
Employees
20
